Company Name, Ticker, Suppliers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
STML's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Stemline Therapeutics Inc News
Stemline Therapeutics Inc's Dividend Payout
Stemline Therapeutics Inc's Net Income Growth
Stemline Therapeutics Inc Business Description
Stemline Therapeutics Inc Executive Officers
Economic Indicators
Fundamentals
Stemline Therapeutics Inc Growth Rates
Stemline Therapeutics Inc Profitability
Stemline Therapeutics Inc Valuation
Stemline Therapeutics Inc Management Effectiveness
Stemline Therapeutics Inc Financial Strength
Stemline Therapeutics Inc Efficiency
Stemline Therapeutics Inc Dividend
Financials
Stemline Therapeutics Inc Business Segments
Stemline Therapeutics Inc Income Statement
Stemline Therapeutics Inc Balance Sheets
Stemline Therapeutics Inc Cash Flow Statement
Stemline Therapeutics Inc Geographic Information
Suppliers
Stemline Therapeutics Inc Suppliers Performance
STML Suppliers Stock Performance
STML Suppliers Growth Rates
STML Suppliers Data
STML Suppliers Efficiency
STML Suppliers Management Effectiveness
STML Suppliers Valuation
STML Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Stemline Therapeutics Inc Market Share
Stemline Therapeutics Inc Competition Performance
Stemline Therapeutics Inc Competitors Results
STML Competitors Stock Performance
STML Competitors Growth Rates
STML Workforce Efficiency at the Competitors
STML Competitors Efficiency
STML Competitors Management Effectiveness
STML Competitors Valuation
Customers & Markets
Stemline Therapeutics Inc Customers Demand
STML Customers Expenditure Growth Rates
STML Customers Performance
STML Customers Stock Performance
STML Customers Growth Rates
STML Workforce Efficiency at the Customers
STML Customers Efficiency
STML Customers Management Effectiveness
STML Customers Valuation
STML Customers by Companys' Segments
Charts & Quotes
Stemline Therapeutics Inc Comparison Charts
STML OHLC Charts
STML's Tehnical Upper Indicators
STML's Tehnical Lower Indicators
STML's Weekly Charts
STML's Monthly Charts
Stemline Therapeutics Inc's Profile
Company Charts and Quotes
Stemline Therapeutics Inc News
Stemline Therapeutics Inc's Executive Officers
Stemline Therapeutics Inc's Income Statement
Stemline Therapeutics Inc's Balance Sheets
Stemline Therapeutics Inc's Cash Flow Statement
Stemline Therapeutics Inc's Profitability
Stemline Therapeutics Inc's Financials
Stemline Therapeutics Inc's Fundamentals
Stemline Therapeutics Inc's Suppliers
Stemline Therapeutics Inc's Competitors
Stemline Therapeutics Inc's Markets & Customers
Stemline Therapeutics Inc's Market Share
STML's Suppliers Valuation
STML's Competitors Valuation
STML's Charts Percentage Volume Oscillator
Stemline Therapeutics Inc's Customers Workforce Efficiency
Economic Indicators
Total Debt to Equity by Industry
Financial Strength Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Housing Starts
News
Economy News
Stock News
Energy Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• F. Cash Flow Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Stemline Therapeutics Inc
(
STML
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Stemline Therapeutics Inc's Yearly Free Cash Flow Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Free Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
STML Annual Free Cash Flow Growth
2019
2018
2017
2016
2015
Y / Y Annual Free Cash Flow Change
-
-
-
-
-
Annual Free Cash Flow (in millions $)
$-67.75
$-72.29
$-49.75
$0.00
$0.00
STML Company Profile
>>
Back to STML Fundamentals at a Glance
>>
Back to STML Growth Comparisons
Annual Free Cash Flow Growth Comment
Stemline Therapeutics Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2019 Annual Free Cash Flow within Healthcare Sector
Y/Y Free Cash Flow Growth %
2019 Annual Free Cash Flow
Teva Pharmaceutical Industries Limited
-87.58 %
$ 223.000 millions
Jazz Pharmaceuticals Plc
-6.34 %
$ 669.975 millions
Nektar Therapeutics